tipo
- journal article
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial
Documento
- doi:10.1016/s0140-6736(21)02392-8
- http://dx.doi.org/10.1016/S0140-6736(21)02392-8
- http://dx.doi.org/10.1016/s0140-6736(21)02392-8
- http://https://www.sciencedirect.com/science/article/pii/S0140673621023928?casa_token=btzt1WUBfosAAAAA:c4-6wtQBrQ55OtaPAxwsluf6tmT7qbX0YiQVR9473d5hO1VvG2ZNLc--BynNUbkOz_iB6t5x][doi:10.1016/s0140-6736(21)02392-8
- https://www.thelancet.com/article/S0140-6736(21)02392-8/fulltext][doi:10.1016/s0140-6736(21)02392-8
- Visão geral
- Identidade
- Informação adicional documento
- Outro
- Ver todos
Visão geral
autores
data de publicação
- 2021-01-01